0000805928-23-000009.txt : 20230201
0000805928-23-000009.hdr.sgml : 20230201
20230201184529
ACCESSION NUMBER: 0000805928-23-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230130
FILED AS OF DATE: 20230201
DATE AS OF CHANGE: 20230201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MARIANI PETER J
CENTRAL INDEX KEY: 0001222357
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36046
FILM NUMBER: 23578234
MAIL ADDRESS:
STREET 1: C/O GUIDANT CORP
STREET 2: 111 MONUMENT CIRCLE #2900
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46204-5129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axogen, Inc.
CENTRAL INDEX KEY: 0000805928
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411301878
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: (386) 462-6817
MAIL ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
FORMER COMPANY:
FORMER CONFORMED NAME: AxoGen, Inc.
DATE OF NAME CHANGE: 20111004
FORMER COMPANY:
FORMER CONFORMED NAME: LECTEC CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
wf-form4_167529511485643.xml
FORM 4
X0306
4
2023-01-30
0
0000805928
Axogen, Inc.
AXGN
0001222357
MARIANI PETER J
111 W OAK AVE.
SUITE 500
TAMPA
FL
33602
0
1
0
0
EVP & Chief Financial Officer
Common Stock
2023-01-30
4
M
0
20939
5.04
A
63047
D
Common Stock
2023-01-30
4
S
0
14111
9.69
D
48936
D
Common Stock
2023-01-31
4
M
0
20939
5.04
A
69875
D
Common Stock
2023-01-31
4
S
0
14320
9.55
D
55555
D
Common Stock
2023-02-01
4
M
0
20940
5.04
A
76495
D
Common Stock
2023-02-01
4
S
0
14550
9.36
D
61945
D
Employee Stock Option (right to purchase)
5.04
2023-01-30
4
M
0
20939
0
D
2020-03-01
2023-03-01
Common Stock
20939.0
41879
D
Employee Stock Option (right to purchase)
5.04
2023-01-31
4
M
0
20939
0
D
2020-03-01
2023-03-01
Common Stock
20939.0
20940
D
Employee Stock Option (right to purchase)
5.04
2023-02-01
4
M
0
20940
0
D
2020-03-01
2023-03-01
Common Stock
20940.0
0
D
The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, in order to exercise options that are scheduled to expire on March 1, 2023.
The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.37 to $9.95 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.36 to $9.77 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.20 to $9.50 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
All shares of Common Stock underlying the employee stock option were fully vested on March 1, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on March 1, 2017 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.
/s/Peter Mariani
2023-02-01